← All trials
NCT05975892
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 30, 2018
- Primary completion
- Aug 30, 2022
- Completion date
- Aug 30, 2024
- First posted
- Aug 4, 2023
- Last posted
- Aug 4, 2023
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Instituto Venezolano de Investigaciones CientificasLead sponsor
- Instituto Venezolano de Investigaciones CientificasOverall official - principal investigator
- Instituto Venezolano de Investigaciones CientificasReponsible party - principal investigator
- Universidad Central de VenezuelaCollaborator
- Hospital Central Dr. Plácido D. Rodriguez Rivero, San Felipe, YaracuyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.